Earnings Snapshot: Novartis Q2 tops earnings and revenue estimates; full-year 2026 outlook reaffirmed

By FXJuly 21, 2026No Comments1 Min Read

Previous ArticleBurnham Puts Sterling on Bond Vigilante Watch

Next Article Further upside likely towards 0.7100

Eurozone banks tighten lending standards further as geopolitical risks weigh on credit conditions

By FXJuly 21, 20260

Eurozone banks tighten lending standards further as geopolitical risks weigh on credit conditions !”#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz !”#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz…

Further upside likely towards 0.7100

July 21, 2026

Earnings Snapshot: Novartis Q2 tops earnings and revenue estimates; full-year 2026 outlook reaffirmed

July 21, 2026

Burnham Puts Sterling on Bond Vigilante Watch

July 21, 2026

What's Hot

Eurozone banks tighten lending standards further as geopolitical risks weigh on credit conditions

Further upside likely towards 0.7100

Earnings Snapshot: Novartis Q2 tops earnings and revenue estimates; full-year 2026 outlook reaffirmed

Earnings Snapshot: Novartis Q2 tops earnings and revenue estimates; full-year 2026 outlook reaffirmed

Eurozone banks tighten lending standards further as geopolitical risks weigh on credit conditions

Further upside likely towards 0.7100

Burnham Puts Sterling on Bond Vigilante Watch

EUR/USD Analysis for July 21, 2026: Fresh Trend Forming as ECB Decision Looms